AI Insight
A researcher at the University of Central Florida has developed a patent-pending technology using microscopic bubbles, described as cells approximately 500 times thinner than a human hair, designed to target and treat both cancer cells and cardiovascular disease. The technology has been licensed to a university donor with the goal of advancing it toward clinical trials. These "smart" microbubbles are engineered to deliver therapeutic effects at a cellular level with high precision.
Why it matters
If successfully validated through clinical trials, this technology could offer a minimally invasive and highly targeted treatment approach for two of the leading causes of death globally, potentially reducing side effects associated with conventional therapies such as chemotherapy.
A cell 500 times thinner than a human hair could heal hearts and kill cancer cells, thanks to a patent-pending technology created by a University of Central Florida researcher and now licensed to a university donor in hopes of getting it to clinical trials.
Source: Researcher develops 'smart, tiny bubbles' to treat cancer and heart disease